Ekso Bionics Holdings Inc (EKSO)

4.57
0.30 6.90
NASDAQ : Health Care
Prev Close 4.27
Open 4.27
Day Low/High 4.25 / 4.71
52 Wk Low/High 3.45 / 9.38
Volume 151.37K
Avg Volume 306.40K
Exchange NASDAQ
Shares Outstanding 21.88M
Market Cap 95.84M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ekso Bionics To Exhibit Ekso GT Robotic Exoskeleton At AAPM&R And AMRPA Annual Meetings

Ekso Bionics To Exhibit Ekso GT Robotic Exoskeleton At AAPM&R And AMRPA Annual Meetings

Five Educational Sessions Featuring Robotic Rehabilitation

To Andrew Left, This Is 'the Most Overvalued Stock in the World'

To Andrew Left, This Is 'the Most Overvalued Stock in the World'

The short-seller says Cyberdyne is a dog unlikely to find its way into U.S. markets.

Ekso Bionics Announces New Data To Be Presented At 55th ISCoS Annual Scientific Meeting

Ekso Bionics Announces New Data To Be Presented At 55th ISCoS Annual Scientific Meeting

New data from Pan-Euro Study and other clinical evidence in the field of exoskeleton therapy

Human Exoskeletons Are Helping Get Stroke and Spinal Cord Victims Walking Again

Human Exoskeletons Are Helping Get Stroke and Spinal Cord Victims Walking Again

The days of people confined to a wheelchair because of a stroke or a spinal cord injury may be coming to an end in the not too distant future.

Ekso Bionics Announces First Patient Enrolled In Important Multi-Center WISE Trial

Ekso Bionics Announces First Patient Enrolled In Important Multi-Center WISE Trial

Ekso Bionics Sponsors U.S.-based study of patients with chronic incomplete Spinal Cord Injury

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABEV, ACM, ACTS, BID, CC, COH, COKE, DSCI, EGRX, FNV, NWS, SHO, SSNC Downgrades: AMBC, HHC, HLF, LXFR, ROG, TCP Initiations: APLE, CNXR, EKSO, GNL, HLTH, LIND Read on to get TheStreet Quant Ratings' detailed report:

Ekso Bionics Announces Inaugural Open House Event

Ekso Bionics Announces Inaugural Open House Event

Early findings on using Ekso GT with stroke patients to be presented by leader in motor recovery research

Ekso GT™ Robotic Exoskeleton Cleared By FDA For Use With Stroke And Spinal Cord Injury Patients

Ekso GT™ Robotic Exoskeleton Cleared By FDA For Use With Stroke And Spinal Cord Injury Patients

First robotic exoskeleton cleared for use with stroke and spinal cord injury levels to C7

Ekso Bionics™ Selected For Development Of Next-Generation DARPA Exoskeleton

Ekso Bionics™ Selected For Development Of Next-Generation DARPA Exoskeleton

Ekso Bionics to Create Flexible Exoskeleton for Soldiers; New Approach Has Potential to Revolutionize Wearable Robotics